A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Synovial Biopsy Study of JNJ-38518168 in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Trial Profile

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Synovial Biopsy Study of JNJ-38518168 in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Discontinued
Phase of Trial: Phase II

Latest Information Update: 15 Jul 2015

At a glance

  • Drugs Toreforant (Primary) ; Methotrexate
  • Indications Rheumatoid arthritis
  • Focus Biomarker; Pharmacodynamics
  • Sponsors Janssen Research & Development
  • Most Recent Events

    • 31 Jul 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 08 May 2014 Planned number of patients changed from 24 to 25 as reported by ClinicalTrials.gov.
    • 12 Aug 2013 Actual initiation date changed from May 2013 to Jul 2013, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top